SCHEMBL8428121

SCHEMBL8428121

CCOC(=O)COc1ccc(Br)c(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.55
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
POLB P06746 1/20 0.53
GAA P10253 4/20 0.52
KDM4E B2RXH2 2/20 0.52
HSD17B10 Q99714 2/20 0.52
ADORA2B P29275 1/20 0.52
NPSR1 Q6W5P4 2/20 0.51
ALDH1A1 P00352 6/20 0.51
HPGD P15428 4/20 0.51
MAPT P10636 3/20 0.51
CYP1A2 P05177 2/20 0.51
CYP2C19 P33261 2/20 0.51
LMNA P02545 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
NTSR1 P30989 1/20 0.51
CASP1 P29466 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14721005 0.91 HPGD (0.56) PTPN1POLBGAAKDM4EHSD17B10
SCHEMBL2134115 0.84 PTPN1 (0.53) PTPN1
SCHEMBL27642525 0.84 SMN1; SMN2 (0.59) MEN1KMT2APOLBGAAKDM4E
SCHEMBL7038455 0.84 GAA (0.56) PTPN1MEN1KMT2AGAAKDM4E
SCHEMBL23605917 0.83 GAA (0.52) PTPN1MEN1KMT2APOLBGAA
SCHEMBL3929739 0.82 PTPN1 (0.57) PTPN1MEN1KMT2AGAAKDM4E
SCHEMBL8603637 0.81 HPGD (0.50) PTPN1MEN1KMT2APOLBGAA
SCHEMBL6809898 0.81 ALDH1A1 (0.51) PTPN1MEN1KMT2APOLBGAA
SCHEMBL5531605 0.81 GAA (0.53) PTPN1MEN1KMT2APOLBGAA
SCHEMBL16569366 0.81 KDM4E (0.53) PTPN1GAAKDM4EHSD17B10NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5922733-A ADMINISTERING TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS SUCH AS ANXIETY, DEPRESSION, EPILEPSY, OBSESSIVE COMPULSIVE DISORDERS, ANOREXIA, BULIMIA AND ALZHEIMER'S DISEASE SMITHKLINE BEECHAM P.L.C. (GB) 1999-07-13 US disclosed
EP-0770076-A1 BENZOCONDENSED FIVE MEMBERED HETEROCYCLE CARBOXAMIDES AS 5HT2B/2C RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-05-02 EP disclosed
WO-1996002537-A1 BENZOCONDENSED FIVE MEMBERED HETEROCYCLE CARBOXAMIDES AS 5HT2B/2C RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-02-01 WO disclosed